Vanguard Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $81.7M | Buy |
|
|||||
|
2020
Q4 | $35.2M | Buy |
|
|||||
|
2020
Q3 | $7.17M | Sell |
|
|||||
|
2020
Q2 | $9.4M | Sell |
|
|||||
|
2020
Q1 | $3.64M | Buy |
|
|||||
|
2019
Q4 | $7.32M | Sell |
|
|||||
|
2019
Q3 | $6.28M | Buy |
|
|||||
|
2019
Q2 | $9.47M | Sell |
|
|||||
|
2019
Q1 | $26.8M | Buy |
|
|||||
|
2018
Q4 | $12.5M | Sell |
|
|||||
|
2018
Q3 | $31.3M | Buy |
|
|||||
|
2018
Q2 | $34.5M | Buy |
|
|||||
|
2018
Q1 | $36.3M | Buy |
|
|||||
|
2017
Q4 | $39.7M | Buy |
|
|||||
|
2017
Q3 | $71.3M | Buy |
|
|||||
|
2017
Q2 | $49.8M | Sell |
|
|||||
|
2017
Q1 | $59.9M | Sell |
|
|||||
|
2016
Q4 | $109M | Buy |
|
|||||
|
2016
Q3 | $90.4M | Buy |
|
|||||
|
2016
Q2 | $60.9M | Buy |
|
|||||
|
2016
Q1 | $41.7M | Buy |
|
|||||
|
2015
Q4 | $34.3M | Buy |
|
|||||
|
2015
Q3 | $9.97M | Buy |
|
|||||
|
2015
Q2 | $14.3M | Buy |
|
|||||
|
2015
Q1 | $12.1M | Buy |
|
|||||
|
2014
Q4 | $8.41M | Buy |
|
|||||
|
2014
Q3 | $3.59M | Buy |
|
|||||
|
2014
Q2 | $3.86M | Buy |
|
|||||
|
2014
Q1 | $4.55M | Buy |
|
|||||
|
2013
Q4 | $665K | Buy |
|